Wordt geladen...
Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?
Temporary ovarian suppression with gonadotropin-releasing hormone agonist during chemotherapy might be a reliable strategy not only to preserve ovarian function but also to increase the likelihood of becoming pregnant after the end of cytotoxic therapy. The findings of Blumenfeld et al. are consiste...
Bewaard in:
| Gepubliceerd in: | Oncologist |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AlphaMed Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718439/ https://ncbi.nlm.nih.gov/pubmed/26463868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0373 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|